Results 141 to 150 of about 2,689,763 (159)

Phosphorescent Ir (III) complexes as cellular staining agents for biomedical molecular imaging

Coordination Chemistry Reviews, 2020
Xuemei Wang, Fawad Ur Rehman, Sana Shaikh   +2 more
exaly  

Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study.

Archives of Internal Medicine, 2000
J. Heit, Marc D. Silverstein, Marc D. Silverstein, D. Mohr, T. Petterson, W. O'Fallon, L. J. Melton   +6 more
semanticscholar   +1 more source

Co-oxidation of As(III) and Fe(II) by oxygen through complexation between As(III) and Fe(II)/Fe(III) species

Water Research, 2018
, , Chengshuai Liu
exaly  

Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial.

Journal of the American Medical Association (JAMA), 2002
S. Steinhubl, Peter B. Berger, J. Tift Mann III, Edward T. A. Fry, A. Delago, C. Wilmer, E. J. Topol   +6 more
semanticscholar   +1 more source

Gallium(III) and indium(III) alkoxides and aryloxides

Coordination Chemistry Reviews, 2006
Claire Carmalt
exaly  

Competitive adsorption of As(III), As(V), Sb(III) and Sb(V) onto ferrihydrite in multi-component systems: Implications for mobility and distribution

Journal of Hazardous Materials, 2017
Pengfei Qi, Pichler Thomas
exaly  

SOCIAL security for physicians. III. Survivorship benefits; the bait.

Journal of the American Medical Association, 2000
openaire   +1 more source

STUDY FINDS UP TO HALF OF PHASE III CLINICAL TRIALS SUCCESSFUL

Ca-A Cancer Journal for Clinicians, 2008
exaly  

Role of randomized phase III trials in an era of effective targeted therapies

Nature Reviews Clinical Oncology, 2011
Richard Schilsky, Sharma Manish R, Schilsky Richard L   +2 more
exaly  

Communication with the Fatally III

Ca-A Cancer Journal for Clinicians, 1965
exaly